Leading pharma company delivers next-level quality and compliance — a case study

Supplied by Vaisala Pty Ltd on Wednesday, 23 March, 2022

LSNE (a PCI Pharma company) supports commercially approved medical devices and drug products to over 30 countries across North America, South America, Europe, Africa, Middle East and Asia.

Learn about an advanced continuous monitoring system LSNE adopted to monitor multiple environments, including walk-in or reach-in freezers and refrigerators, and cleanrooms.

Discover how to easily monitor multiple parameters, GMP compliance and data integrity at the highest quality in your lab.

Related White Papers

Next-gen tech raises the bar for episcopic microscopy

Learn about advanced technology that...

DNA/RNA extraction from formalin fixed paraffin embedded tissue samples

To find out about an automation-friendly process for extracting total nucleic acid from...

Minimise product contamination with elemental impurity testing

Learn about elemental impurity testing and how the recent innovation of microwave closed vessel...

Content from other channels on our network

Calls for health-based approach to drug policy

DHCRC project to deliver benchmarking tool for AI in health

NHMRC announces new council

Cancer recurrence anxiety: clinical pathway for health professionals

Certain hormone treatments linked to increased heart disease risk

Electrolyser manufacturing a $1.7 billion opportunity: report

Solar-powered desalination system requires no additional power

Fortescue awarded $10 million ARENA grant to develop fast charger

Building a critical infrastructure security dream team

Hazer secures $6.2 million WA Government grant

Maximising yield and minimising waste in dairy processing

Hygiena acquires Nexcor Food Safety Technologies

Six plant-based foods with brain-boosting benefits

NZ's Alliance Group uses AI tech for meat quality insights

Red meat exports hit new records

All content Copyright © 2024 Westwick-Farrow Pty Ltd